Covered recipient · General Payments record
VALERIA MARIN
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2024
$958.33
- Reported across 36 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $958.33 | 36 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $502.31 | 15 |
| Ascendis Pharma Inc | $115.27 | 5 |
| DEXCOM, INC. | $102.08 | 3 |
| Kyowa Kirin, Inc. | $101.35 | 5 |
| TOLMAR, INC. | $62.86 | 4 |
| BETA BIONICS, INC. | $24.80 | 1 |
| IBSA Pharma Inc. | $17.84 | 1 |
| Insulet Corporation | $17.61 | 1 |
| Azurity Pharmaceuticals, Inc. | $14.21 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $958.33 | 36 |
Payment records · PY2024 (36)
Sorted by paying entity, then date · as published by CMS
Program year 2024
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Ascendis Pharma Inc | $25.42 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133843590 | CMS |
| Ascendis Pharma Inc | $26.83 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133845681 | CMS |
| Ascendis Pharma Inc | $23.05 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133847390 | CMS |
| Ascendis Pharma Inc | $19.21 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133848863 | CMS |
| Ascendis Pharma Inc | $20.76 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133850439 | CMS |
| Azurity Pharmaceuticals, Inc. | $14.21 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134019314 | CMS |
| BETA BIONICS, INC. | $24.80 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087873611 | CMS |
| Dexcom, Inc. | $53.13 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153390948 | CMS |
| Dexcom, Inc. | $24.32 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153390950 | CMS |
| Dexcom, Inc. | $24.63 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153390952 | CMS |
| IBSA Pharma Inc. | $17.84 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142978216 | CMS |
| Insulet Corporation | $17.61 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116808367 | CMS |
| Kyowa Kirin, Inc. | $19.59 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127056923 | CMS |
| Kyowa Kirin, Inc. | $21.24 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127056925 | CMS |
| Kyowa Kirin, Inc. | $25.20 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127056927 | CMS |
| Kyowa Kirin, Inc. | $19.36 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127056929 | CMS |
| Kyowa Kirin, Inc. | $15.96 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127056931 | CMS |
| Novo Nordisk Inc | $11.10 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100541698 | CMS |
| Novo Nordisk Inc | $23.79 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100524205 | CMS |
| Novo Nordisk Inc | $122.07 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100446357 | CMS |
| Novo Nordisk Inc | $12.82 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100462108 | CMS |
| Novo Nordisk Inc | $110.20 | 04/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100309913 | CMS |
| Novo Nordisk Inc | $18.82 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100657503 | CMS |
| Novo Nordisk Inc | $9.87 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100468886 | CMS |
| Novo Nordisk Inc | $6.73 | 07/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100541804 | CMS |
| Novo Nordisk Inc | $24.92 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100590896 | CMS |
| Novo Nordisk Inc | $24.35 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100310229 | CMS |
| Novo Nordisk Inc | $7.35 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100297921 | CMS |
| Novo Nordisk Inc | $7.38 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100585714 | CMS |
| Novo Nordisk Inc | $103.12 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100584710 | CMS |
| Novo Nordisk Inc | $7.26 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100336813 | CMS |
| Novo Nordisk Inc | $12.53 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100534931 | CMS |
| Tolmar, Inc. | $15.09 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138712714 | CMS |
| Tolmar, Inc. | $15.38 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138712716 | CMS |
| Tolmar, Inc. | $16.99 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138711792 | CMS |
| Tolmar, Inc. | $15.40 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138711794 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.